Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Neoplasm Metastasis 7Multiple Myeloma 6Prostatic Neoplasms 5Pain 3Uterine Cervical Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Uterine Cervical Dysplasia 1Urologic Neoplasms 1Small Cell Lung Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Osteoporosis 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Lung Neoplasms 1Kidney Neoplasms 1Humoral Hypercalcemia Of Malignancy 1Hematologic Neoplasms 1Giant Cell Tumors of Bone 1Giant Cell Tumor of Bone 1Disease Progression 1Carcinoma, Ductal, Breast 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

valrubicin 1temsirolimus 1pembrolizumab 1palbociclib 1niraparib 1enfortumab vedotin 1cabozantinib 1atezolizumab 1Zoledronic Acid 1Valproic Acid 1VMBP protocol 1Trastuzumab 1Sunitinib 1Standard of Care 1Sirolimus 1Prednisone 1Nivolumab 1Mitomycin 1Immunoglobulin G 1Gemcitabine 1Etoposide 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urologic Neoplasms × Zoledronic Acid × Clear all
NCT00226954 2020-03-18

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Stanford University

Phase 2 Terminated
23 enrolled
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡